Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Getting the whole picture: adding patient-reported outcomes to adjuvant endocrine treatment evaluation in premenopausal breast cancer patients.
Oberguggenberger A, Goebel G, Beer B, Oberacher H, Meraner V, Sztankay M, Sperner-Unterweger B, Zeimet AG, Marth C, Hubalek M, Holzner B. Oberguggenberger A, et al. Among authors: oberacher h. Breast J. 2014 Sep-Oct;20(5):555-7. doi: 10.1111/tbj.12323. Epub 2014 Jul 8. Breast J. 2014. PMID: 25040193 No abstract available.
A fatal intoxication case involving topiramate.
Beer B, Libiseller K, Oberacher H, Pavlic M. Beer B, et al. Among authors: oberacher h. Forensic Sci Int. 2010 Oct 10;202(1-3):e9-11. doi: 10.1016/j.forsciint.2010.04.035. Epub 2010 May 21. Forensic Sci Int. 2010. PMID: 20494535
Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study.
Beer B, Schubert B, Oberguggenberger A, Meraner V, Hubalek M, Oberacher H. Beer B, et al. Among authors: oberacher h. Anal Bioanal Chem. 2010 Oct;398(4):1791-800. doi: 10.1007/s00216-010-4075-z. Epub 2010 Aug 22. Anal Bioanal Chem. 2010. PMID: 20730580
Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs).
Oberguggenberger A, Hubalek M, Sztankay M, Meraner V, Beer B, Oberacher H, Giesinger J, Kemmler G, Egle D, Gamper EM, Sperner-Unterweger B, Holzner B. Oberguggenberger A, et al. Among authors: oberacher h. Breast Cancer Res Treat. 2011 Jul;128(2):553-61. doi: 10.1007/s10549-011-1378-5. Epub 2011 Feb 11. Breast Cancer Res Treat. 2011. PMID: 21311968
Adherence evaluation of endocrine treatment in breast cancer: methodological aspects.
Oberguggenberger AS, Sztankay M, Beer B, Schubert B, Meraner V, Oberacher H, Kemmler G, Giesinger J, Gamper E, Sperner-Unterweger B, Marth C, Holzner B, Hubalek M. Oberguggenberger AS, et al. Among authors: oberacher h. BMC Cancer. 2012 Oct 15;12:474. doi: 10.1186/1471-2407-12-474. BMC Cancer. 2012. PMID: 23066928 Free PMC article.
Does obesity interfere with anastrozole treatment? Positive association between body mass index and anastrozole plasma levels.
Hubalek M, Oberguggenberger A, Beer B, Meraner V, Sztankay M, Oberacher H, Schubert B, Wildt L, Seeber B, Giesinger J, Kemmler G, Holzner B, Sperner-Unterweger B. Hubalek M, et al. Among authors: oberacher h. Clin Breast Cancer. 2014 Aug;14(4):291-6. doi: 10.1016/j.clbc.2013.12.008. Epub 2013 Dec 27. Clin Breast Cancer. 2014. PMID: 24468298
141 results